Benjamin F. Edwards & Company’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Benjamin F. Edwards & Company’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-110	Closed	-$16K	–	1140
2016 Q1	$16K	Sell	110 -42	-28%	-$5.97K	﹤0.01%	716
2015 Q4	$23K	Hold	152	–	–	0.01%	662
2015 Q3	$22K	Sell	152 -238	-61%	-$33.3K	﹤0.01%	695
2015 Q2	$56K	Buy	390 +238	+157%	+$33.9K	0.01%	569
2015 Q1	$21K	Buy	+152	New	+$23.4K	﹤0.01%	759

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Benjamin F. Edwards & Company's TARO Position: Q2 2016 in Review

Benjamin F. Edwards & Company sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 110 shares — an estimated $16K sold.

Benjamin F. Edwards & Company first reported a position in TARO in Q1 2015 and held it in 5 quarters. The position peaked at $56K in Q2 2015. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Benjamin F. Edwards & Company reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Benjamin F. Edwards & Company sold 110 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $16K.
Benjamin F. Edwards & Company first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 5 quarters.
Benjamin F. Edwards & Company's Taro Pharmaceutical Industries Ltd. position peaked at $56K in Q2 2015.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2016, filed 11 Jul 2016.